Target intelligence / Profile preview

Protein kinase AMP-activated non-catalytic subunit beta-2 (PRKAB2)

Target
PRKAB2
Molecular classification
Enzyme regulatory subunit, Kinase regulatory subunit, Other (AMPK complex component)
01

Overview

Protein kinase AMP-activated non-catalytic subunit beta-2 (PRKAB2) is a regulatory subunit of the AMP-activated protein kinase (AMPK) complex, which acts as a key cellular energy sensor. The AMPK heterotrimer consists of a catalytic alpha subunit and regulatory beta (including PRKAB2) and gamma subunits. Upon cellular energy stress, AMPK is activated, shifting cellular metabolism toward energy-generating processes while inhibiting anabolic pathways such as fatty acid and cholesterol synthesis. The PRKAB2-encoded beta-2 subunit serves as a scaffold crucial for assembly and stabilization of the AMPK complex and contributes to tissue specificity—being highly expressed in skeletal muscle and also implicated in cardiac and neuronal development. PRKAB2 has been functionally associated with various metabolic diseases, cancer, and neurodevelopmental syndromes, and is targeted by drugs that modulate AMPK activity—either directly or indirectly. PRKAB2 is considered a bona fide therapeutic target due to its central role in cellular metabolism and disease.

Other names
5'-AMP-activated protein kinase subunit beta-2AMPK subunit beta-2AMPK beta 2AMPK beta-2 chainAMP-activated protein kinase beta 2 non-catalytic subunit5'-AMP-activated protein kinase, beta-2 subunitProtein kinase, AMP-activated, beta 2 non-catalytic subunit
02

Mechanism of action

Activation of the AMPK complex, leading to phosphorylation and inactivation of metabolic enzymes (e.g., ACC, HMGCR), shifting the cell from anabolic to catabolic metabolism and inhibiting cell growth and biosynthetic processes. Regulation of AMPK localization and assembly through post-translational modification of PRKAB2 (e.g., ubiquitination, sumoylation).

03

Biological functions

Cellular energy metabolismSignal transductionRegulation of biosynthesis (fatty acid, cholesterol)Regulation of cell growth and proliferationRegulation of cellular polarity
04

Disease associations

Cardiovascular diseaseObesity/metabolic syndrome-related disordersCancerNeurodevelopmental and neuropsychiatric disordersRenal disease (e.g., diabetic nephropathy)Chromosome 1q21.1 deletion/duplication syndromes
05

Safety considerations

Off-target metabolic effects when modulating AMPK systemicallyRisk of affecting pathways controlling cardiac and neuronal development, muscle function, and lipid metabolismPotential impact on cell proliferation in tissues with high PRKAB2 expression
06

Interacting drugs

Metformin

3 more in the full profile.

07

Biomarkers

PRKAB2 expression or modification status in target tissues (e.g., skeletal muscle, adipose tissue)Phosphorylation state of AMPK substrates (e.g., acetyl-CoA carboxylase)AMPK activity assays (used in monitoring efficacy of AMPK-targeting agents)

Beyond the preview

Go deeper on Protein kinase AMP-activated non-catalytic subunit beta-2 (PRKAB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein kinase AMP-activated non-catalytic subunit beta-2 (PRKAB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call